Esophageal Disorders Clinical Trials

A listing of Esophageal Disorders medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

Research Center
Birmingham Alabama 35233

The ORBIT 1 Clinical Research Study for Eosinophilic Esophagitis (EoE)

Arizona

Research Center
Tucson Arizona 85710

The ORBIT 1 Clinical Research Study for Eosinophilic Esophagitis (EoE)

Arkansas

NEW

Research Center
North Little Rock Arkansas 72117

FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis

California

NEW

Research Center
Canoga Park California 91303

FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis

Research Center
Chula Vista California 91910

The ORBIT 1 Clinical Research Study for Eosinophilic Esophagitis (EoE)

NEW

Research Center
El Cajon California 92020

FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis

NEW

Research Center
Los Angeles California 90048

FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis

NEW

Research Center
Mountain View California 94040

FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis

NEW

Research Center
San Diego California 92114

FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis

NEW

Research Center
San Diego California 92123

FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis

NEW

Research Center
San Pablo California 94806

FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis

Colorado

Research Center
Aurora Colorado 80045

The ORBIT 1 Clinical Research Study for Eosinophilic Esophagitis (EoE)

Research Center
Colorado Springs Colorado 80907

The ORBIT 1 Clinical Research Study for Eosinophilic Esophagitis (EoE)

Research Center
Lone Tree Colorado 80124

The ORBIT 1 Clinical Research Study for Eosinophilic Esophagitis (EoE)

Connecticut

NEW

Research Center
 Hamden Connecticut 6518

FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis

NEW

Research Center
Hamden Connecticut 6518

FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis

Florida

NEW

Research Center
Inverness Florida 34452

FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis

NEW

Research Center
Lake City Florida 32055

FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis

NEW

Research Center
Lauderdale Lakes Florida 33319

FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis

NEW

Research Center
Miami Florida 33135

FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis

Georgia

Research Center
Atlanta Georgia 30342

The ORBIT 1 Clinical Research Study for Eosinophilic Esophagitis (EoE)

Illinois

NEW

Research Center
Oak Lawn Illinois 60453

FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis

NEW

Research Center
Rockford Illinois 61107

FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis

Indiana

Research Center
New Albany Indiana 47150

The ORBIT 1 Clinical Research Study for Eosinophilic Esophagitis (EoE)

Iowa

Research Center
Iowa City Iowa 52242

The ORBIT 1 Clinical Research Study for Eosinophilic Esophagitis (EoE)

Kansas

NEW

Research Center
Topeka Kansas 66606

FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis

Research Center
Topeka Kansas 66606

The ORBIT 1 Clinical Research Study for Eosinophilic Esophagitis (EoE)

Louisiana

Research Center
Metairie Louisiana 70006

The ORBIT 1 Clinical Research Study for Eosinophilic Esophagitis (EoE)

Research Center
Shreveport Louisiana 71105

The ORBIT 1 Clinical Research Study for Eosinophilic Esophagitis (EoE)

Research Center
West Monroe Louisiana 71291

The ORBIT 1 Clinical Research Study for Eosinophilic Esophagitis (EoE)

Maryland

NEW

Research Center
Elkridge Maryland 21075

FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis

Michigan

Research Center
Chesterfield Michigan 48047

The ORBIT 1 Clinical Research Study for Eosinophilic Esophagitis (EoE)

NEW

Research Center
Wyoming Michigan 49519

FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis

Montana

Research Center
Bozeman Montana 59718

The ORBIT 1 Clinical Research Study for Eosinophilic Esophagitis (EoE)

New Jersey

Research Center
Marlton New Jersey 08053

The ORBIT 1 Clinical Research Study for Eosinophilic Esophagitis (EoE)

New York

Research Center
Great Neck New York 11023

The ORBIT 1 Clinical Research Study for Eosinophilic Esophagitis (EoE)

Research Center
New York New York 10029

The ORBIT 1 Clinical Research Study for Eosinophilic Esophagitis (EoE)

North Carolina

Research Center
Asheville North Carolina 28801

The ORBIT 1 Clinical Research Study for Eosinophilic Esophagitis (EoE)

NEW

Research Center
Chapel Hill North Carolina 27599

FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis

Research Center
Chapel Hill North Carolina 27514

The ORBIT 1 Clinical Research Study for Eosinophilic Esophagitis (EoE)

NEW

Research Center
Charlotte North Carolina 28277

FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis

Research Center
Charlotte North Carolina 28277

The ORBIT 1 Clinical Research Study for Eosinophilic Esophagitis (EoE)

NEW

Research Center
Greensboro North Carolina 27405

FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis

NEW

Research Center
Mooresville North Carolina 28117

FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis

Research Center
Mt. Airy North Carolina 27030

The ORBIT 1 Clinical Research Study for Eosinophilic Esophagitis (EoE)

NEW

Research Center
Raleigh North Carolina 27607

FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis

NEW

Research Center
Raleigh North Carolina 27612

FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis

NEW

Research Center
Salisbury North Carolina 28144

FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis

NEW

Research Center
Winston Salem North Carolina 27103

FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis